Back to Screener

Healthcare

Kiniksa Pharmaceuticals, Ltd.(KNSA)

Live Price

Offline

$56.89

-3.79% today

1Y Change

+90.28%

Window

Jun 26, 2025 โ†’ Jun 17, 2026

Market Cap
$4.00B
Revenue Growth
+60.1%
EPS Growth
+233.3%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 26, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Kiniksa Pharmaceuticals, Ltd. (KNSA) is a Healthcare stock with a market cap of $4.00B and listed on NASDAQ. The stock last traded around $56.89 and up 90.3% across the available one-year price window (Jun 26, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of +60.1%, EPS growth of +233.3%, a dividend yield of 0.0%. What stands out right now is revenue +60.1%, EPS +233.3%, free cash flow 0.0% with operating margin 12.4% and ROIC 12.3%. Valuation already assumes a fairly strong business story at P/E 56.4 and price/sales 5.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines KNSA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

KNSA vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

KNSA

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

KNSA Max Drawdown

-21.12%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for KNSA and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 5, 26
โ€”
Est 0.21
โ€”
โ€”
Est 207123.3B
โ€”
May 5
โ€”
Feb 24, 26
โœ—
0.17
Est 0.29
-41.4%
202127.0B
Est 200809.0B
+0.7%
Feb 24
โ€”
Oct 28, 25
โœ—
0.23
Est 0.33
-30.3%
180855.0B
Est 197094.6B
-8.2%
Oct 28
โ€”
Jul 29, 25
โœ“
0.23
Est 0.18
+27.8%
156797.0B
Est 166484.4B
-5.8%
Jul 29
โ€”
Apr 29, 25
โœ“
0.11
Est 0.02
+450.0%
137785.0B
Est 131876.0B
+4.5%
Apr 29
โ€”
Feb 25, 25
โœ—
-0.12
Est -0.06
-100.0%
122536.0B
Est 123415.8B
-0.7%
Feb 25
โ€”
Oct 29, 24
โœ—
-0.18
Est -0.02
-662.4%
112214.0B
Est 123376.8B
-9.1%
Oct 29
โ€”
Jul 23, 24
โœ“
-0.06
Est -0.09
+33.3%
108631.0B
Est 110300.0B
-1.5%
Jul 23
โ€”
Apr 23, 24
โœ—
-0.25
Est -0.14
-78.6%
79858.0B
Est 78460.0B
+1.8%
Apr 23
โ€”
Feb 28, 24
โœ“
0.04
Est -0.11
+136.4%
83395.0B
Est 72020.0B
+15.8%
Feb 28
โ€”
Oct 31, 23
โœ—
-0.20
Est -0.18
-11.1%
67046.0B
Est 64450.0B
+4.0%
Oct 31
โ€”
Jul 25, 23
โœ“
-0.02
Est -0.16
+87.5%
71473.0B
Est 62200.0B
+14.9%
Jul 25
โ€”
May 2, 23
โ€”
-0.18
Est -0.18
0.0%
48345.0B
Est 46580.0B
+3.8%
May 2
โ€”
Feb 28, 23
โœ“
0.06
Est -0.23
+126.1%
61884.0B
Est 45116.4B
+37.2%
Feb 28
โ€”
Nov 1, 22
โœ“
0.67
Est 0.38
+76.3%
99135.0B
Est 93575.6B
+5.9%
Nov 1
โ€”
Aug 3, 22
โœ“
-0.29
Est -0.43
+32.6%
26972.0B
Est 28420.5B
-5.1%
Aug 3
โ€”
May 3, 22
โœ“
-0.36
Est -0.52
+30.8%
32189.0B
Est 30103.7B
+6.9%
May 3
โ€”
Feb 22, 22
โœ—
-0.53
Est -0.44
-20.4%
18745.0B
Est 17599.4B
+6.5%
Feb 22
โ€”
Nov 1, 21
โœ“
-0.44
Est -0.63
+30.2%
12095.0B
Est 8780.0B
+37.8%
Nov 1
โ€”
Aug 3, 21
โœ“
-0.61
Est -0.69
+11.6%
7704.0B
Est 7704.0B
0.0%
Aug 3
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener